Provided herein is disclosure about the development and characterization
of an antibody (mPA7) which binds to antigen CD46 which is present on a
variety of human cancers from ovary, breast, lung, prostate, colon,
kidney, and pancreas. Methods of diagnosing and treating various cancers
by using antibodies such as mPA7 directed against this antigen are also
disclosed.